Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.20
Ask: 1.30
Change: -0.15 (-10.71%)
Spread: 0.10 (8.333%)
Open: 1.40
High: 1.40
Low: 1.25
Prev. Close: 1.40
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

Fri, 03rd May 2024 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

Fletcher King PLC, up 26% at 44.00 pence, 12-month range 31.00p-49.00p. It reports a "strong second half business performance", a turnaround from the more "cautionary business outlook" it gave back in December. Revenue for the year ended April 30 "is now expected to be materially higher than management expectations". Pretax profit is expected to be between two and three times higher than the GBP192,000 it reported for the prior year.

----------

Angle PLC, up 11% at 15.20 pence, 12-month range 9.07p-37.40p. The firm strikes a deal with AstraZeneca to develop a "Parsortix-based androgen receptor" detection assay to be used in prostate cancer studies. Medical diagnostics provider Angle says the deal is worth GBP550,000.

----------

AIM - LOSERS

----------

Physiomics PLC, down 16% at 1.26p, 12-month range 0.90p-3.29p. The data science company, focused on new therapeutics and personalised medicine solutions, warns several large contracts have taken longer than expected to be signed. It predicts total income for the year to June 30 will decline to a range of GBP600,000-GBP650,000 as a result. It adds: "The company is in the final stages of negotiation for two projects (one with an existing client and one with a potential new client), the total value of which is expected to be, in aggregate, approximately GBP350,000. Whilst the board anticipates that the contracts for these two projects will be signed in FY24, the majority of the revenue is now expected be recognised in the company's next financial year ending 30 June 2025, and accordingly the board's expectations for FY25 revenues have been correspondingly increased. "

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
10 Mar 2023 12:06

IN BRIEF: Physiomics wins further contract from Bicycle Therapeutics

Physiomics PLC - London-based oncology consultancy, which uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions - Gets a further contract from existing client Bicycle Therapeutics relating to an undisclosed programme. Expects this to be completed in Physiomics's current financial year.

Read more
10 Mar 2023 08:51

Physiomics wins further contract with Bicycle Therapeutics

(Sharecast News) - Oncology consultancy Physiomics revealed on Friday that it had been awarded a further contract by existing client Bicycle Therapeutics.

Read more
7 Mar 2023 17:05

Physiomics confident despite weaker first half

(Sharecast News) - Oncology consultancy firm Physiomics reported revenue of £0.34m in its first half on Tuesday - a slight decrease from the £0.37m reported in the same period a year earlier.

Read more
7 Mar 2023 14:39

EARNINGS SUMMARY: Foxtons profit doubles; Reach yearly profit dips

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Jan 2023 11:17

Physiomics COO Chassagnole changes title to chief scientific officer

(Alliance News) - Physiomics PLC on Friday said Christophe Chassagnole's job title has changed from chief operating officer to chief scientific officer.

Read more
11 Jan 2023 12:04

Physiomics announces another contract with client Cancer Research UK

(Alliance News) - Physiomics PLC on Wednesday said it entered into a further contract with its existing client Cancer Research UK to conduct analyses of a blood cancer treatment.

Read more
9 Jan 2023 11:27

AIM WINNERS & LOSERS: musicMagpie flies; video game shares fall

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
9 Jan 2023 11:14

Physiomics shares jump on dosing tool study findings

(Alliance News) - Physiomics PLC on Monday hailed new opportunities in the emerging personalised dosing space, following the completion of its Partner study.

Read more
15 Nov 2022 15:38

UK shareholder meetings calendar - next 7 days

Wednesday 16 November 
European Opportunities Trust  PLCAGM
Finsbury Food Group PLCAGM
GreenX Metals LtdAGM
Jubilee Metals Group PLCAGM
Litigation Capital Management LtdAGM
Marble Point Loan Financing LtdAGM
McBride PLCAGM
Petra Diamonds LtdAGM
Smiths Group PLCAGM
ThinkSmart LtdAGM
Thursday 17 November 
Advance Energy PLCAGM
Close Brothers Group PLCAGM
Cordel Group PLCAGM
Eagle Eye Solutions Group PLCAGM
Finsbury Food Group PLCAGM
FW Thorpe PLCAGM
Henderson EuroTrust PLCAGM
JD Wetherspoon PLCAGM
Kier Group PLCAGM
New Star Investment Trust PLCAGM
Reabold Resources PLCGM re requisitioned resolutions to remove board
Ricardo PLCAGM
Seraphim Space Investment Trust PLCAGM
Superdry PLCGM re annual and remuneration report
Supermarket Income REIT PLCAGM
Thor Mining PLCAGM
Friday 18 November 
MJ Gleeson PLCAGM
Just Eat Takeaway.com N.V.EGM
Marula Mining PLCAGM
NIOX Group PLCGM share premium account cancellation
Sovereign Metals LtdAGM
Monday 21 November 
Manchester & London Investment Trust PLCAGM
Mountview Estates PLCGM re re-electing Chair Powell, non-exec Archibald
RPS Group PLCGM cash offer agreement
Yamana Gold IncGM Gold Fields offer
Tuesday 22 November 
Alpha FX Group PLCGM re name change
Artemis Resources LtdAGM
Fonix Mobile PLCAGM
Kingswood Holdings LtdAGM
Origin Enterprises PLCAGM
Physiomics PLCAGM
Quantum Exponential Group PLCAGM
Rainbow Rare Earths LtdAGM
Sabien Technology Group PLCAGM
Town Centre Securities PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
10 Nov 2022 14:26

IN BRIEF: Physiomics shares rise on Ankyra contract extension

Physiomics PLC - Oncology consultancy based in Oxford, England - Says it has been awarded a further contract by existing client Ankyra Therapeutics. The contract builds on work announced in March, and is expected to complete in the first quarter of 2023.

Read more
10 Nov 2022 10:54

AIM WINNERS & LOSERS: Manolete swings to loss amid case troubles

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
12 Oct 2022 12:42

Physiomics inks deal to work with Cancer Research UK

(Sharecast News) - Modelling and simulation-focussed consultancy Physiomics that it has signed an agreement to work with Cancer Research UK, it announced on Wednesday.

Read more
12 Oct 2022 11:18

AIM WINNERS & LOSERS: Physiomics wins deal; DeepVerge eyes cash raise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
12 Oct 2022 10:52

Physiomics surges on contract win with Cancer Research UK

(Alliance News) - Physiomics PLC shares jumped on Wednesday after it signed an agreement to work with Cancer Research UK.

Read more
4 Oct 2022 10:06

IN BRIEF: Physiomics wins third contract from Numab Therapeutics

Physiomics PLC - oncology consultancy based in Oxford, England - Wins third contract by an existing client, Numab Therapeutics. Says it will use its PKPD modelling capabilities to support the translation of pre-clinical to clinical data with a focus on dose selection. The project is expected to be completed between now and the end of 2022.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.